Sign in
4

Changes in Ownership

PUMA BIOTECHNOLOGY, INC. Filed Acc 0001437749-23-017612

Director sold 27,000 shares at $3.45 ($93,269)

  • Director acquired 27,000 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
WILSON TROY EDWARD Director 2023-06-13 Sale 10b5-1 −27,000 $3.45 $93,269 350 D
WILSON TROY EDWARD Director 2023-06-13 Grant or award 10b5-1 +27,000 27,350 D
Open-market sales · 27,000 sh · avg $3.45 · $93,269
Loading xslF345X04/rdgdoc.xml…